Literature DB >> 29043395

Measuring Flow Hemodynamic Indices and Oxygen Consumption in Children with Pulmonary Hypertension: A Comparison of Catheterization and Phase-Contrast MRI.

Michal Schäfer1,2, Uyen Truong3,4, Lorna P Browne4,5, Gareth J Morgan3, Michael Ross3, Richard Ing6, Kendall S Hunter3,4, Vitaly O Kheyfets3,4, Steven H Abman7, D Dunbar Ivy3, Neil Wilson3.   

Abstract

We sought to compare pulmonary flow hemodynamic indices obtained by Fick and thermodilution catheterization techniques with phase-contrast MRI (PC-MRI) in children with diverse etiologies of pulmonary arterial hypertension (PAH). Calculation of pulmonary flow ([Formula: see text]) using the Fick principle in most catheter laboratories relies on an estimate of oxygen consumption which may limit its reliability. Flow hemodynamic indices acquired from thirty patients with PAH who underwent successful same-day PC-MRI and catheterization were evaluated for absolute and percent bias. Comparison of [Formula: see text] between PC-MRI and Fick revealed poor agreement with an absolute bias of 0.96 ± 0.53 L/min/m2 and percent bias of 27.7 ± 19.6%. Same analysis between PC-MRI and thermodilution revealed better agreement as demonstrated by absolute bias 0.64 ± 0.47 L/min/m2 and percent bias 16.8 ± 12.3%. Retrospectively calculated [Formula: see text] from PC-MRI and LaFarge equations revealed poor agreement, with an absolute bias of 33.4 ± 21.6 mL/min/m2 and percent bias of 25.8 ± 12.6%. We found that Fick-derived flow hemodynamics dramatically differs from PC-MRI computed metrics in children with PAH. The non-invasive nature of PC-MRI and short acquisition time is ideal for pediatric flow evaluation and may offer a novel route of absolute flow and resistance assessment when combined with cardiac catheterization.

Entities:  

Keywords:  Catheterization; Phase-contrast MRI; Pulmonary flow; Pulmonary hypertension

Mesh:

Year:  2017        PMID: 29043395     DOI: 10.1007/s00246-017-1751-1

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  27 in total

1.  Quantitative 2D and 3D phase contrast MRI: optimized analysis of blood flow and vessel wall parameters.

Authors:  A F Stalder; M F Russe; A Frydrychowicz; J Bock; J Hennig; M Markl
Journal:  Magn Reson Med       Date:  2008-11       Impact factor: 4.668

2.  MRI catheterization in cardiopulmonary disease.

Authors:  Toby Rogers; Kanishka Ratnayaka; Robert J Lederman
Journal:  Chest       Date:  2014-01       Impact factor: 9.410

Review 3.  Prognostic factors in pediatric pulmonary arterial hypertension: A systematic review and meta-analysis.

Authors:  Mark-Jan Ploegstra; Willemijn M H Zijlstra; Johannes M Douwes; Hans L Hillege; Rolf M F Berger
Journal:  Int J Cardiol       Date:  2015-01-27       Impact factor: 4.164

4.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

5.  Reproducibility and interobserver variability of systolic blood flow velocity and 3D wall shear stress derived from 4D flow MRI in the healthy aorta.

Authors:  Pim van Ooij; Alexander L Powell; Wouter V Potters; James C Carr; Michael Markl; Alex J Barker
Journal:  J Magn Reson Imaging       Date:  2015-07-03       Impact factor: 4.813

6.  In vivo assessment of wall shear stress in the atherosclerotic aorta using flow-sensitive 4D MRI.

Authors:  Andreas Harloff; Andrea Nussbaumer; Simon Bauer; Aurélien F Stalder; Alex Frydrychowicz; Cornelius Weiller; Jürgen Hennig; Michael Markl
Journal:  Magn Reson Med       Date:  2010-06       Impact factor: 4.668

7.  Pediatric Pulmonary Hypertension: Guidelines From the American Heart Association and American Thoracic Society.

Authors:  Steven H Abman; Georg Hansmann; Stephen L Archer; D Dunbar Ivy; Ian Adatia; Wendy K Chung; Brian D Hanna; Erika B Rosenzweig; J Usha Raj; David Cornfield; Kurt R Stenmark; Robin Steinhorn; Bernard Thébaud; Jeffrey R Fineman; Titus Kuehne; Jeffrey A Feinstein; Mark K Friedberg; Michael Earing; Robyn J Barst; Roberta L Keller; John P Kinsella; Mary Mullen; Robin Deterding; Thomas Kulik; George Mallory; Tilman Humpl; David L Wessel
Journal:  Circulation       Date:  2015-11-03       Impact factor: 29.690

8.  Cardiac catheterization in children with pulmonary hypertensive vascular disease: consensus statement from the Pulmonary Vascular Research Institute, Pediatric and Congenital Heart Disease Task Forces.

Authors:  Maria Jesus Del Cerro; Shahin Moledina; Sheila G Haworth; Dunbar Ivy; Maha Al Dabbagh; Hanaa Banjar; Gabriel Diaz; Alexandria Heath-Freudenthal; Ahmed Nasser Galal; Tilman Humpl; Snehal Kulkarni; Antonio Lopes; Ana Olga Mocumbi; G D Puri; Beyra Rossouw; S Harikrishnan; Anita Saxena; Patience Udo; Lina Caicedo; Omar Tamimi; Ian Adatia
Journal:  Pulm Circ       Date:  2016-03       Impact factor: 3.017

9.  Characterization of CMR-derived haemodynamic data in children with pulmonary arterial hypertension.

Authors:  Michal Schäfer; D Dunbar Ivy; Alex J Barker; Vitaly Kheyfets; Robin Shandas; Steven H Abman; Kendall S Hunter; Uyen Truong
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2017-04-01       Impact factor: 6.875

10.  Wall shear stress measured by phase contrast cardiovascular magnetic resonance in children and adolescents with pulmonary arterial hypertension.

Authors:  Uyen Truong; Brian Fonseca; Jamie Dunning; Shawna Burgett; Craig Lanning; D Dunbar Ivy; Robin Shandas; Kendall Hunter; Alex J Barker
Journal:  J Cardiovasc Magn Reson       Date:  2013-09-13       Impact factor: 5.364

View more
  5 in total

1.  Elevated Interleukin-6 Levels Predict Clinical Worsening in Pediatric Pulmonary Arterial Hypertension.

Authors:  Jenny Y Chen; Megan Griffiths; Jun Yang; Melanie K Nies; Rachel L Damico; Catherine E Simpson; R Dhananjay Vaidya; Stephanie Brandal; D Dunbar Ivy; Eric D Austin; William C Nichols; Michael W Pauciulo; Katie Lutz; Erika B Rosenzweig; Russel Hirsch; Delphine Yung; Allen D Everett
Journal:  J Pediatr       Date:  2020-08       Impact factor: 4.406

2.  Non-Invasive Cardiac Output Determination Using Magnetic Resonance Imaging and Thermodilution in Pulmonary Hypertension.

Authors:  Lindsey A Crowe; Léon Genecand; Anne-Lise Hachulla; Stéphane Noble; Maurice Beghetti; Jean-Paul Vallée; Frédéric Lador
Journal:  J Clin Med       Date:  2022-05-11       Impact factor: 4.964

3.  Prognostic Value of Change in Cardiac Index After Prostacyclin Initiation in Pediatric Pulmonary Hypertension.

Authors:  Patrick D Evers; Paul J Critser; Michelle Cash; Melissa Magness; Russel Hirsch
Journal:  Pediatr Cardiol       Date:  2020-09-24       Impact factor: 1.655

4.  Metalloproteinases and their inhibitors are associated with pulmonary arterial stiffness and ventricular function in pediatric pulmonary hypertension.

Authors:  Michal Schäfer; D Dunbar Ivy; Kathleen Nguyen; Katie Boncella; Benjamin S Frank; Gareth J Morgan; Kathleen Miller-Reed; Uyen Truong; Kelley Colvin; Michael E Yeager
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-06-04       Impact factor: 5.125

5.  EXPRESS: Statement on imaging and pulmonary hypertension from the Pulmonary Vascular Research Institute (PVRI).

Authors:  David G Kiely; David Levin; Paul Hassoun; David D Ivy; Pei-Ni Jone; Jumaa Bwika; Steven M Kawut; Jim Lordan; Angela Lungu; Jeremy Mazurek; Shahin Moledina; Horst Olschewski; Andrew Peacock; Goverdhan Dutt Puri; Farbod Rahaghi; Michal Schafer; Mark Schiebler; Nicholas Screaton; Merryn Tawhai; Edwin Jr Van Beek; Anton Vonk-Noordegraaf; Rebecca R Vanderpool; John Wort; Lan Zhao; Jim Wild; Jens Vogel-Claussen; Andrew J Swift
Journal:  Pulm Circ       Date:  2019-03-18       Impact factor: 3.017

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.